Pfizer explores acquisition of Germany’s MediGene
Pfizer, the US drugmaker, is exploring the possibility of acquiring MediGene and has held talks with the management of the Munich based company.
Big Pharma Drug Deals Target Asian Sources
Pfizer Inc., GlaxoSmithKline Plc and other U.S. and European pharmaceutical companies will increasingly sign long-term contracts with Asian drugmakers, according to a Citigroup Inc. report.
Celgene net profit down on charge from Pharmion acquisition
Biopharmaceutical company Celgene Corp posts large net loss Thursday following a charge from its $2.9 billion acquisition of Pharmion Corp.
Anchor Health Centers delivers high-quality healthcare with new facilities
Anchor Health Centers’ business model enables it to deliver high-quality healthcare to the people of Naples, Florida – and to leverage contracting and purchasing resources.
FDA rejects Merck’s new cholesterol drug
An experimental cholesterol drug being developed by Merck & Company has failed to win approval from the Food and Drug Administration, the company said on Monday.
Acambis wins smallpox vaccine contract from US government
Acambis Plc, the vaccine maker, has won a $425 million contract to supply the US government with a smallpox vaccine for ten years.